Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

PRP treatment may help with alopecia areata, especially in newer cases.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

MRI helps evaluate androgenetic alopecia severity.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Platelet-Rich Plasma treatment has limited and temporary effects on severe Alopecia Areata and does not prevent relapses.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Effective treatments for severe alopecia areata are still lacking.